Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05084833 · ClinicalTrials.gov registry record · NA
ASPIRES (Activating Cancer Survivors and Their Primary Care Providers to Increase Colorectal Cancer Screening) Study
A NA study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT05084833 is a NA study that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 300 participants.
The verdict
NCT05084833, a NA study, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
The primary purpose of this study is to assess the best method for encouraging high-risk cancer survivors to get screened for colorectal cancer at the recommended age.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Patient activation
- BEHAVIORAL Primary care provider activation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-02-14 |
| Est. Completion | 2025-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05084833
The ClinicalTrials.gov registry entry for NCT05084833 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT05084833 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05084833 about?
NCT05084833 is a clinical study titled "ASPIRES (Activating Cancer Survivors and Their Primary Care Providers to Increase Colorectal Cancer Screening) Study". The primary purpose of this study is to assess the best method for encouraging high-risk cancer survivors to get screened for colorectal cancer at the recommended age.
What is the current status of trial NCT05084833?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2022-02-14. Estimated completion is 2025-10-30.
What interventions are being tested in trial NCT05084833?
The interventions under investigation include: Control (BEHAVIORAL), Patient activation (BEHAVIORAL), Primary care provider activation (BEHAVIORAL).
Who is sponsoring clinical trial NCT05084833?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.